Cytokinetics (CYTK) Prepaid Assets (2010 - 2026)

Cytokinetics (CYTK) has reported Prepaid Assets for 17 consecutive years, with $13.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets fell 11.94% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $13.9 million (down 11.94% YoY), while the FY2025 annual figure was $17.0 million, up 11.22% from the prior year.
• Prepaid Assets declined to $13.9 million in Q1 2026 per CYTK's latest filing, from $17.0 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $20.0 million in Q2 2025 and bottomed at $6.7 million in Q3 2024.
• Historically, Prepaid Assets has averaged $14.6 million across 5 years, with a median of $14.3 million in 2022.
• Annual changes were most pronounced in 2022 — Prepaid Assets surged 180.77% — and 2024, when it tumbled 66.13%.
• Cytokinetics' Prepaid Assets stood at $12.5 million in 2022, then slipped by 4.16% to $11.9 million in 2023, then grew by 27.9% to $15.3 million in 2024, then grew by 11.22% to $17.0 million in 2025, then decreased by 17.99% to $13.9 million in 2026.
• Business Quant data shows CYTK's Prepaid Assets at $13.9 million in Q1 2026, $17.0 million in Q4 2025, and $13.0 million in Q3 2025.